M. Wolf

737 total citations
23 papers, 531 citations indexed

About

M. Wolf is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, M. Wolf has authored 23 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in M. Wolf's work include Blood properties and coagulation (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Lung Cancer Treatments and Mutations (5 papers). M. Wolf is often cited by papers focused on Blood properties and coagulation (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Lung Cancer Treatments and Mutations (5 papers). M. Wolf collaborates with scholars based in Germany, France and United States. M. Wolf's co-authors include R. Egbring, K. Havemann, Rainer Seitz, M. Maasberg, R. Pfab, Michael Kraus, Christophe Michon, Y. Humblet, B. Régnier and A. G. Saimot and has published in prestigious journals such as Annals of Oncology, Advances in experimental medicine and biology and Digestive Diseases and Sciences.

In The Last Decade

M. Wolf

23 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Wolf Germany 10 175 117 111 93 83 23 531
Saloua Ladeb Tunisia 15 95 0.5× 120 1.0× 145 1.3× 230 2.5× 85 1.0× 55 688
A. Wehmeier Germany 11 72 0.4× 61 0.5× 76 0.7× 259 2.8× 112 1.3× 31 591
Tarek Ben Othman Tunisia 11 57 0.3× 88 0.8× 80 0.7× 154 1.7× 51 0.6× 32 484
Amel Lakhal Tunisia 11 61 0.3× 81 0.7× 48 0.4× 139 1.5× 45 0.5× 33 410
Patricia Pisciotto United States 14 167 1.0× 25 0.2× 68 0.6× 368 4.0× 31 0.4× 29 808
Xavier Delabranche France 11 182 1.0× 82 0.7× 34 0.3× 74 0.8× 203 2.4× 16 527
Imma Fischer Germany 12 300 1.7× 142 1.2× 96 0.9× 143 1.5× 44 0.5× 34 796
Salman Naseem Adil Pakistan 16 203 1.2× 53 0.5× 155 1.4× 317 3.4× 53 0.6× 87 774
Federica Giannotti Switzerland 15 189 1.1× 21 0.2× 122 1.1× 222 2.4× 90 1.1× 47 632
William L. Bayer United States 15 249 1.4× 51 0.4× 44 0.4× 312 3.4× 53 0.6× 40 740

Countries citing papers authored by M. Wolf

Since Specialization
Citations

This map shows the geographic impact of M. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Wolf more than expected).

Fields of papers citing papers by M. Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Wolf. The network helps show where M. Wolf may publish in the future.

Co-authorship network of co-authors of M. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of M. Wolf. A scholar is included among the top collaborators of M. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Wolf. M. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolf, M., Thorsten Steinberg, Konstantin J. Scholz, et al.. (2025). The rise and evolving role of Fusobacterium nucleatum subspecies. Current Research in Microbial Sciences. 9. 100414–100414. 1 indexed citations
4.
Bonaterra, Gabriel A., Florian Wakenhut, M. Wolf, et al.. (2014). Cytoprotection by omega-3 fatty acids as a therapeutic drug vehicle when combined with nephrotoxic drugs in an intravenous emulsion: Effects on intraglomerular mesangial cells. Toxicology Reports. 1. 843–857. 3 indexed citations
5.
Bonaterra, Gabriel A., et al.. (2013). Synthesis of 5‐Fluorouridine Nucleolipid Derivatives and Their Cytostatic/Cytotoxic Activities on Human HT‐29 Colon Carcinoma Cells. Chemistry & Biodiversity. 10(12). 2235–2246. 13 indexed citations
6.
Hecker, Matthias, Natascha Sommer, Oleg Pak, et al.. (2013). Impact of Short‐ and Medium‐Chain Fatty Acids on Mitochondrial Function in Severe Inflammation. Journal of Parenteral and Enteral Nutrition. 38(5). 587–594. 36 indexed citations
7.
Douillard, Jean‐Yves, Salvatore Siena, Josep Tabernero, et al.. (2009). 10LBA Randomized phase 3 study of panitumumab with FOLFOX4 compared to FOLFOX4 alone as 1st-line treatment (tx) for metastatic colorectal cancer (mCRC): the PRIME trial. European Journal of Cancer Supplements. 7(3). 6–6. 63 indexed citations
9.
Wolf, M., et al.. (1997). Prognostic impact of an activation of coagulation in lung cancer. Annals of Oncology. 8(8). 781–784. 19 indexed citations
10.
Seitz, Rainer, Michael Kraus, M. Wolf, et al.. (1993). Activation of coagulation and fibrinolysis in patients with lung cancer. Blood Coagulation & Fibrinolysis. 4(2). 249–254. 71 indexed citations
11.
Seitz, Rainer, et al.. (1990). Cytochemical Determination of Intracellular Polymorphonuclear Leukocyte Elastase Content in Patients with Severe Bacterial Infection and Septicaemia Correlated with Coagulation Parameters. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 27(6). 575–580. 1 indexed citations
12.
Görg, Christian, et al.. (1990). Prognostic value of response to chemotherapy using ultrasound in lung cancer with metastatic liver involvement.. PubMed. 57(3-4). 70–3. 9 indexed citations
13.
Seitz, Rainer, M. Wolf, R. Egbring, & K. Havemann. (1989). The disturbance of hemostasis in septic shock: role of neutrophil elastase and thrombin, effects of antithrombin III and plasma substitution*. European Journal Of Haematology. 43(1). 22–28. 75 indexed citations
14.
Seitz, Rainer, et al.. (1989). Reduced fibrinolytic capacity and its restoration by plasminogen substitution in acute renal failure.. PubMed. 11(1). 39–46. 1 indexed citations
15.
Marche, C, B. Régnier, A. G. Saimot, et al.. (1989). Intestinal infections in patients with acquired immunodeficiency syndrome. Digestive Diseases and Sciences. 34(5). 773–780. 112 indexed citations
16.
Seitz, Rainer, M. Wolf, R. Egbring, & K. Havemann. (1988). Neutrophil Elastase, Thrombin and Plasmin in Septic Shock. Advances in experimental medicine and biology. 240. 481–484. 1 indexed citations
17.
Seitz, Rainer, et al.. (1987). Participation and interactions of neutrophil elastase in haemostatic disorders of patients with severe infections. European Journal Of Haematology. 38(3). 231–240. 35 indexed citations
18.
Berndt, H, et al.. (1966). [Cyclophosphamide therapy of bronchial carcinoma].. PubMed. 61(15). 586–92. 2 indexed citations
19.
Koransky, W. & M. Wolf. (1955). �ber die Beeinflussung der enteralen Natrium- und Kaliumbindung an Kationenaustauscher. Naunyn-Schmiedeberg s Archives of Pharmacology. 224(3). 2 indexed citations
20.
Herken, H. & M. Wolf. (1952). �ber die therapeutische Verwendung von Kationenaustauschern. Journal of Molecular Medicine. 30(23-24). 529–537. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026